IJCEMR

Article http://dx.doi.org/10.26855/ijcemr.2024.07.006

Determining the Cardioprotective Effect of Mongolian Medicine Shaosha-7 by Expression of Bcl-2 and Bax Proteins

TOTAL VIEWS: 639

Xiangjun Yang1,2, Khaliun Erdenebat3, Uuganbayar Baatartsogt4, Khishigjargal Ser-Od1, Ambaga Miyegombo6, Bayarmaa Enkhbat3,6,*

1International School of Mongolian Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 999097-15160, Mongolia.

2Department of Cardiology, Affiliated Hospital of Inner Mongolia University for Nationalities, Tongliao 028002, Inner Mongolia, China.

3School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar 999097-15160, Mongolia.

4Institute of Traditional Medicine and Technology of Mongolia, Ulaanbaatar 999097-15160, Mongolia.

5New Medicine Medical University, Ulaanbaatar 999097-15160, Mongolia.

6Mongolia-Japan Hospital, Mongolian National University of Medical Sciences, Ulaanbaatar 999097-15160, Mongolia.

*Corresponding author: Bayarmaa Enkhbat

Published: August 16,2024

Abstract

Background: Ischemia/reperfusion (I/R) plays an imperative role in the expansion of cardiovascular disease. Shaosha-7 has been exhibited to possess antioxidant, anti-inflammatory, antiaggregant, and vasodilator properties. Shaosha-7, a combination of the traditional herb and Mongolian medicine, is effective and safe in treating atherosclerosis in clinical trials. We assess the cardioprotective effects of Shaosha-7 against myocardial ischemia and reperfusion (MI/R) injury in rats and explore its possible mechanism. Methods: Seventy male Sprague Dawley rats were randomized into seven groups, 10 rats in each: normal healthy group (NG), non-MI/R group (Sham), MI/R injury group (Control group) were treated with 2 ml/100 g distilled water, once a day for 15 days and, MI/R group treated with a low, medium, high dose of Shaosha-7 at the doses of 0.4, 0.8 and 1.6 g/kg (Drug group 1,2,3 ) respectively, once a day for 15 days, and MI/R group treated with 0.3 g/kg Danshen (Positive drug group), once a day for 15 days. MI/R was induced by ligation of the left anterior descending coronary artery (LAD) for 30 minutes, then the thoracic cavity was closed after reperfusion in the Control and Drug groups. In the Sham group, the LAD was exposed without occlusion. Blood samples were collected from the carotid artery (10 rats in each group) after 2 hours of reperfusion, to determine the levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-18 (IL-18), cardiac troponin I (cTnI), creatine kinase-myocardial band (CK-MB), lactate dehydrogenase (LDH), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) using enzyme-linked immunosorbent assays. The expression of NF-кB was detected by immunohistochemistry. The animals were then sacrificed and the hearts were harvested for histopathology and western blot analysis. Infarct size was measured in the remaining five rats in each group after 24 hours of reperfusion. Results: Shaosha-7 significantly decreased levels of TNF-α, IL-1β, IL-6, IL-18, cTnI, CK-MB, LDH, MDA, GSH-Px, and infarct size through the upregulating the expression of BCL-2 protein and down-regulating the expression of Bax protein. Conclusions: Shaosha-7 is effective in protecting the myocardium against MI/R injury in rats. Its possible cardioprotective mechanism involves inhibition of the inflammatory response and apoptosis following MI/R injury.

References

[1] World Health Organization. (2021, June 11). "Ischemic heart disease deaths of cardiovascular disease." Retrieved from

https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

[2] Health development center. (2022). "Ischemic heart disease deaths of cardiovascular disease." Retrieved from 

http://hdc.gov.mn/media/files.

[3] Badalzadeh, R., Yousefi, B., Majidinia, M., Ebrahimi, H. (2014). Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: Activation of nitric oxide system and mitochondrial KATP channel. J Physiol Sci, 64, 393-400. https://doi.org/10.1007/s12576-014-0333-8.  

[4] Granier, M., Massin, F., Pasquie, J.-L. (2013). Pro- and Anti-Arrhythmic Effects of Anti- Anti-Inflammatory Drugs. Anti-inflamm Antiallergy Agents Med Chem 12, 83-93. https://doi.org/10.2174/1871523011312010010. 

[5] Tse, G., Sun, B., Wong, S.T., Tse, V., Yeo, J.M. (2016). Anti-arrhythmic effects of hypercalcemia in hyperkalemic, langendorff-perfused mouse hearts. Biomed Reports, 5 (3), 301-310. 

[6] Najafi, M., Noroozi, E., Javadi, A., Badalzadeh, R. (2018). Anti-arrhythmogenic and anti-inflammatory effects of troxerutin in ischemia/reperfusion injury of diabetic myocardium. Biomed Pharmacother, 102, 385-391. https://doi.org/ 10.1016/j.biopha.2018.03.047. 

[7] Williams, E.A., Russo, V., Ceraso, S., Gupta, D., Barrett-Jolley, R. (2020). Anti-arrhythmic properties of non-antiarrhythmic medications. Pharmacol. Res., 156, 104762. 

[8] Wu, S.-J., Li, Y.-C., Shi, Z.-W., Lin, Z.-H., Rao, Z.-H., Tai, S.-C., Chu, M.-P., Li, L., Lin, J.-F. (2017). Alteration of cholinergic anti-inflammatory pathway in rat with the ischemic cardiomyopathy-modified electrophysiological function of heart. J Am Heart Assoc., 6 (9). https://doi.org/10.1161/JAHA.117.006510. 

[9] Gatzke, N., Güc, N., Hillmeister, P., Dülsner, A., Le Noble, F., Buschmann, E.E., Ingwersen, M., Bramlage, P., Buschmann, I.R. (2018). Cardiovascular drugs attenuated myocardial resistance against ischemia-induced and reperfusion- induced injury in a rat model of repetitive occlusion. Open Hear, 5 (2). https:// doi.org/10.1136/openhrt-2018-000889. 

[10] Liu, K., Wang, F., Wang, S., Li, W.-N., Ye, Q. (2019). Mangiferin attenuates myocardial ischemia-reperfusion injury via MAPK/NRf-2/HO-1/NF-jB in vitro and in vivo. Oxid Med Cell Longev., 2019, 1-12. 

[11] Yang, H., Jiang, C., Chen, X., He, K., Hu, Y. (2017). Protective effects of sinomenine against LPS-induced inflammation in pig-lets. Microb. Pathog., 110, 573-577. https://doi.org/10.1016/j.micpath.2017.07.044.

[12] 4 principles of medicine. Huh Hot, (1987), pp. 517-520.

[13] Y. Wang, W.B. Lau, E. Gao, et al. Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury Am J Physiol Endocrinol Metab, 298 (3) (2010), p. E663.

[14] M. Amani, S. Jeddi, N. Ahmadiasl, N. Usefzade, J. Zaman Effect of HEMADO on Level of CK-MB and LDH enzymes after ischemia/reperfusion injury in isolated rat heart Bioimpacts, 3 (2) (2013), pp. 101-104.

[15] A. Kutsal, G.S. Saydam, D. Yücel, M. Balk Changes in the serum levels of CK-MB, LDH, LDH1, SGOT and myoglobin due to cardiac surgery J Cardiovasc Surg., 32 (4) (1991), pp. 516-522.

[16] A. Gross, J.M. Mcdonnell, S.J. Korsmeyer BCL-2 family members and the mitochondria in apoptosis.

[17] C. Laulier, B.S. Lopez The secret life of Bcl-2: apoptosis-independent inhibition of DNA repair by Bcl-2 family members Mutat Res Fund Mol Mech Mutagen, 751 (751) (2012), pp. 247-257.

[18] S. Cory, D.C.S. Huang, J.M. Adams. The Bcl-2 family: roles in cell survival and oncogenesis Oncogene, 22 (53) (2003), p. 8590.

[19] P.S. Prince, K. Dhanasekar, S. Rajakumar Preventive effects of vanillic acid on lipids, bax, bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study Cardiovasc Toxicol, 11 (1) (2011), pp. 58-66.

[20] Cao Z, Hu Y, Wu W, et al. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischemia/reperfusion injury. Cardiovasc Res., 2009; 84: 442-451.

[21] Jian Yang, Hong Jiang, Jun Yang, et al. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kB signaling pathway. Mol Cell Biochem., 2009; 330: 39-46.

[22] Han X, Liu JX, Ma MB, et al. Effects of shuangshen tongguan (SSTG) on TNF-alpha, ICAM-1 during myocardial ischemia-reperfusion injury. Zhongguo Zhong Yao Za Zhi, 2004; 29: 1073-1075.

How to cite this paper

Determining the Cardioprotective Effect of Mongolian Medicine Shaosha-7 by Expression of Bcl-2 and Bax Proteins

How to cite this paper: Xiangjun Yang, Khaliun Erdenebat, Uuganbayar Baatartsogt, Khishigjargal Ser-Od, Ambaga Miyegombo, Bayarmaa Enkhbat. (2024) Determining the Cardioprotective Effect of Mongolian Medicine Shaosha-7 by Expression of Bcl-2 and Bax Proteins. International Journal of Clinical and Experimental Medicine Research8(3), 404-409.

DOI: http://dx.doi.org/10.26855/ijcemr.2024.07.006